It has been widely recognized that BDNF-TrkB signaling plays a pivotal role in the pathogenesis and therapeutic mechanisms of depression (Zhang et al., 2014; Shirayama et al., 2015; Yang et al., 2015a; Fang et al., 2018). Here, NTRK2 is linked to depressive symptom measurement.